Factor VIII and IX inhibitors after exposure to heat-treated concentrates

Histological validation of a type 1 diabetes clinical diagnostic model for classification of diabetes.

Diabetic medicine : a journal of the British Diabetic Association·2020

PK-guided personalized prophylaxis with Nuwiq® (human-cl rhFVIII) in adults with severe haemophilia A.

Haemophilia : the official journal of the World Federation of Hemophilia·2017

Predicting the outcomes of using longer-acting prophylactic factor VIII to treat people with severe hemophilia A: a hypothetical decision analysis.

Journal of thrombosis and haemostasis : JTH·2016

The use of enhanced half-life coagulation factor concentrates in routine clinical practice: guidance from UKHCDO.

Haemophilia : the official journal of the World Federation of Hemophilia·2016

Factor X and its deficiency states.

Haemophilia : the official journal of the World Federation of Hemophilia·2016

Clinical experience of factor XI deficiency: the role of fresh frozen plasma and factor XI concentrate.

Haemophilia : the official journal of the World Federation of Hemophilia·2016

Immunogenicity of fractional one-fifth and one-half doses of 17DD yellow fever vaccine compared with full dose in children aged 9-23 months in Uganda: a phase 4, single-blind, randomised clinical trial.

Lancet (London, England)·2026

Efficacy and safety of mitapivat in adults with transfusion-dependent α-thalassaemia or β-thalassaemia (ENERGIZE-T): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial.

Lancet (London, England)·2026

Perioperative durvalumab plus fluorouracil, leucovorin, oxaliplatin, and docetaxel for resectable gastric and gastro-oesophageal junction adenocarcinoma (MATTERHORN): final results of overall survival and event-free survival by pathological response in a global, randomised, double-blind, placebo-controlled, multicentre, phase 3 trial.

Lancet (London, England)·2026

Wildfire smoke and health: current evidence, mechanisms, and future challenges.

Lancet (London, England)·2026

Severe Immune-Related Adverse Events Associated with Durable Antitumor Responses Following Immune Checkpoint Inhibitor Therapy: Two Case Reports.

Cancer management and research·2026

Clonotypic characterization defines B-cell drivers of clonal expansion and intratumor heterogeneity in IgM monoclonal gammopathies.

HemaSphere·2026

A guide to selecting high-performing antibodies for Syntenin-1 (O00560) for use in western blot, immunoprecipitation, and immunofluorescence.

F1000Research·2026

A guide to selecting high-performing renewable antibodies for KIF5A (Q12840) across western blot, immunoprecipitation, and immunofluorescence.

F1000Research·2026

SARS-CoV-2-specific T cells cross-react with tumor-associated antigens via molecular mimicry.

Journal of translational medicine·2026

Beyond the platelet count: A systematic review of artificial intelligence in immune thrombocytopenia.

Blood reviews·2026

Related Experiment Videos

Factor VIII and IX inhibitors after exposure to heat-treated concentrates

Related Concept Videos

Histological validation of a type 1 diabetes clinical diagnostic model for classification of diabetes.

PK-guided personalized prophylaxis with Nuwiq® (human-cl rhFVIII) in adults with severe haemophilia A.

Predicting the outcomes of using longer-acting prophylactic factor VIII to treat people with severe hemophilia A: a hypothetical decision analysis.

The use of enhanced half-life coagulation factor concentrates in routine clinical practice: guidance from UKHCDO.

Factor X and its deficiency states.

Clinical experience of factor XI deficiency: the role of fresh frozen plasma and factor XI concentrate.

Immunogenicity of fractional one-fifth and one-half doses of 17DD yellow fever vaccine compared with full dose in children aged 9-23 months in Uganda: a phase 4, single-blind, randomised clinical trial.

Efficacy and safety of mitapivat in adults with transfusion-dependent α-thalassaemia or β-thalassaemia (ENERGIZE-T): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial.

Wildfire smoke and health: current evidence, mechanisms, and future challenges.

Severe Immune-Related Adverse Events Associated with Durable Antitumor Responses Following Immune Checkpoint Inhibitor Therapy: Two Case Reports.

Clonotypic characterization defines B-cell drivers of clonal expansion and intratumor heterogeneity in IgM monoclonal gammopathies.

A guide to selecting high-performing antibodies for Syntenin-1 (O00560) for use in western blot, immunoprecipitation, and immunofluorescence.

A guide to selecting high-performing renewable antibodies for KIF5A (Q12840) across western blot, immunoprecipitation, and immunofluorescence.

SARS-CoV-2-specific T cells cross-react with tumor-associated antigens via molecular mimicry.

Beyond the platelet count: A systematic review of artificial intelligence in immune thrombocytopenia.

Related Experiment Videos

Factor VIII and IX inhibitors after exposure to heat-treated concentrates

Related Concept Videos

Related Articles